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Abstract. The aim of this study was to assess the clinical spectrum 
of peripartum tuberculosis from the perspective of immunorestitution 
disease. Of 29 patients with peripartum tuberculosis, 27 (93.1%) 
had extrapulmonary tuberculosis, 20 (69%) of whom were affected 
in the central nervous system. Twenty-two (75.9%) patients had no 
clinical features suggestive of tuberculosis during pregnancy. The 
median time from delivery to the onset of immunorestitution was 4 
days, but treatment with anti-tuberculous therapy was delayed for a 
median time of 27 days after the onset of symptoms. Despite 
therapy, 11 (38%) patients died and 4 (13.8%) had residual 
functional deficits. Peripartum tuberculosis is an important 
differential diagnosis of postpartum fever (of unknown origin) 
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without localized signs. 
 
<heading1>Introduction 
The incidence of tuberculosis during pregnancy is increasing in both 
developed and developing countries, especially in the era of HIV 
coinfection [1]. Tuberculosis is well known to be associated with 
immunorestitution disease in HIV-positive patients, in whom 
rebound immunopathological damage may occur during the reversal 
of immunosuppression, achieved by a reduction in the HIV viral load 
and a recovery of CD4+ lymphocyte counts following initiation of 
highly active antiretroviral therapy [2]. In addition, paradoxical 
response during antituberculous therapy has been reported in 
HIV-negative patients [3]. 
Pregnancy is an immunosuppressive process to avoid maternal 
rejection of the fetus. Selective suppression of cell-mediated 
immunity and progressive impairment of lymphocytic reactivity 
towards the purified protein derivative of tuberculin during 
pregnancy have been documented [4]. After delivery of the baby, a 
rebound lymphocytic proliferative response was reported as early as 
24 h after delivery [4]. Therefore, it is not surprising to observe an 
increased in severity of symptoms of tuberculosis in the postpartum 
period. In this report, we describe two patients with peripartum 
tuberculosis from the perspective of immunorestitution disease and 
review the literature on this topic. 
 
<heading1>Materials and Methods 
For the purpose of this study, peripartum tuberculosis is defined as 
an acute deterioration or worsening of clinical symptoms of 
pre-existing tuberculosis during pregnancy or the onset of clinical 
symptoms attributable to Mycobacterium tuberculosis infection 
within 1 month of delivery. Mycobacterium tuberculosis can be 
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present latently or symptomatically during pregnancy. The time to 
development of tuberculosis is defined as the interval between the 
delivery and the onset of clinical symptoms and signs or radiological 
appearance of tuberculosis. 
The English-language literature (1966– 2002) was searched using 
the Medline databases of the National Library of Medicine. The 
keywords of tuberculosis, tuberculous, peripartum, puerperium and 
postpartum were used to select the cases listed in Table 1. All 
case reports and clinical studies that provided full clinical details 
were included in this study if they fit the definition of peripartum 
tuberculosis. The bibliographies cited are also retrieved for further 
analysis where appropriate. Two patients with peripartum 
tuberculosis managed in our center were also reported. 
 
<heading1>Results and Discussion 
Case 1 was a 36-year-old woman admitted to hospital because of 
fever of 5 days' duration at 22 weeks of gestation. She had no 
pulmonary symptoms, and no focus of infection was identified. Her 
leukocyte count was normal, but the differential count revealed 
lymphopenia of 300 cells/μ l. The liver function test was deranged. 
Laboratory investigations for sepsis and ultrasound examination of 
the pelvic region were unremarkable. Intravenous cefuroxime 
750 mg q8 h was started on day 2 of admission. A chest radiograph 
obtained on day 5 was normal. Mantoux test was performed on day 
10, but no induration was detected. 
On day 12 the patient delivered a stillborn fetus vaginally. Eleven 
hours after delivery of the fetus, she went into septic shock and 
respiratory distress, requiring mechanical ventilation and intensive 
care support. She was given intravenous ceftazidime and 
metronidazole as empirical therapy. The chest radiograph revealed 
bilateral nodular opacities. A review of serial chest radiographs 
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showed miliary shadowing in both midzones and lower zones on the 
chest radiograph taken on day 5, which progressed rapidly on the 
day of delivery (day 12), day 13, and day 21. A clinical diagnosis of 
miliary tuberculosis was made. On day 21, antituberulous therapy 
was initiated with isoniazid 300 mg/day, rifampicin 600 mg/day, 
ethambutol 700 mg/day, streptomycin 500 mg IMI/per day, and 
levofloxacin 400 mg/day. Prednisolone 0.5 mg/kg/day was 
administered for 2 weeks and tapered down within 4 weeks. The 
patient was weaned off the ventilator on day 28. Histological 
examination of the placenta revealed granulomatous inflammation 
with the presence of acid-fast bacilli (AFB) on Ziehl-Neelsen 
staining. Subsequently, the patient's sputum was culture positive for 
Mycobacterium tuberculosis, which was susceptible to isoniazid, 
rifampicin, and streptomycin. A test for HIV antibodies was negative. 
Case 2 was a 35-year-old woman with an uneventful antenatal 
period who delivered a preterm baby at week 29 of gestation. She 
had unexplained persistent lymphopenia, with absolute lymphocyte 
counts of 810/μ l and 616/μ l at week 6 and week 20 of gestation, 
respectively. On the day of delivery, she had a transient elevation of 
the absolute lymphocyte count of 2040 cells/μ l; this gradually 
returned to the level of 600 cells/μ l at 1 week post-delivery. She 
developed persistent, high swinging fever 2 days after the delivery, 
but she had no pulmonary symptoms. Laboratory investigations for 
sepsis and an ultrasound study of the pelvic region were negative. 
She was given ceftriaxone, gentamicin, and metronidazole 
empirically. On day 26 her condition deteriorated as she developed 
mental confusion and left-sided hemiparesis. Emergency contrast 
computed tomography revealed a noncontrast enhancing 
hypodense area over the right temporal region, suggestive of 
cerebral infarction. Examination of the cerebrospinal fluid (CSF) 
showed lymphocytic pleocytosis (total cell count of 30x106/l, with 
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56% lymphocytes) and an elevated protein level. A provisional 
diagnosis of tuberculous meningitis with endarteritis of the skull 
base vessels was made. 
Therapy was commenced with oral isoniazid 300 mg/day, rifampicin 
600 mg/day, and pyrazinamide 2 g/day, along intravenous amikacin 
750 mg/day. Subsequently, the CSF culture was positive for 
Mycobacterium tuberculosis sensitive to isoniazid, rifampicin, 
ethambutol, and streptomycin. Antituberculous therapy was 
administered for 12 months, and the patient recovered with residual 
left-sided weakness. Re-evaluation of the histological section of the 
placenta showed a few AFB, compatible with mycobacterial 
endometritis. The test for HIV antibodies was negative. 
A review of the English-language literature revealed a total of 57 
episodes of peripartum tuberculosis. Including the present two 
cases, a total of 29 cases matched our definition (Table 1) [5, 6, 7, 
8, 9, 10, 11, 12, 13, 14]. The age of the patients ranged from 18 to 
36 years, with a median age of 25 years. Two patients had a history 
of pulmonary tuberculosis and one patient was exposed to 
tuberculosis during pregnancy [9, 10]. Only two patients were 
diagnosed with active tuberculosis before delivery, at week 28 and 
week 34 of gestation, respectively; both cases were meningitis. 
Another five patients developed nonspecific symptoms and signs 
suggestive of tuberculosis 2 weeks to 3 months before delivery. The 
median time to onset of symptoms was 4 days (range, 1– 30 days) 
after delivery, with 75.9% of patients experiencing symptoms within 
10 days. Fever occurred in eight patients, three of whom presented 
with pyrexia of unknown origin for 26, 32, and 37 days, respectively. 
Localized symptoms, which included headache, neck stiffness, 
hemiplegia, abdominal pain, respiratory distress, and pleural 
effusion, were present in 12 patients. 
Mycobacterium tuberculosis was cultured from 11 (37.9%) patients, 
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3 of whom had positive smear results for AFB. Baseline Mantoux 
tests were performed in three patients and were negative in all three 
cases. Mantoux tests were performed in seven (24.1%) patients 
during the period of clinical deterioration and were positive in four. A 
surge in lymphocyte counts during clinical deterioration was 
mentioned in one case. Of the 22 patients who were asymptomatic 
during pregnancy, 21 received antituberculosis therapy, at a median 
time of 27 days (range, 7– 36 days) after the onset of symptoms. 
The overall recovery rate was 34.5% (10 patients). Residual 
functional defects such as left-sided hemiparesis and pulmonary 
insufficiency were present in four (13.8%) patients. Eleven patients 
(38%) died of peripartum tuberculosis. 
Peripartum tuberculosis is a rare but important differential diagnosis 
of postpartum fever. Early diagnosis is important yet difficult for 
several reasons. First, few patients have a history of exposure to 
tuberculosis or a history of the disease itself. Second, the clinical 
presentation is often nonspecific in the early stage [7, 14]. Fever can 
be the only presenting symptom, which can make differentiation 
from endometritis, pelvic thrombophlebitis, and acute pyelonephritis 
difficult. As a result of the relative immunosuppression that occurs 
during pregnancy, tuberculin skin tests can be negative in pregnant 
women with tuberculosis, even in those with recent exposure to 
tuberculosis [9]. Occasionally, only Gallium scan but not computed 
tomography was able to detect diffuse peritoneal involvement, and 
subsequently, laparotomy was required to make the definitive 
diagnosis of intraabdominal tuberculosis [14]. 
In this review the clinical presentation of peripartum tuberculosis 
was predominantly extrapulmonary tuberculosis, but this might not 
be representative of the population studied, since publication bias 
may occur in that patients with more severe clinical situations were 
more likely to be reported. However clinicians should be aware of 
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the possibility of extrapulmonary tuberculosis if other causes of 
postpartum fever are excluded. 
We speculate that the acute deterioration in patients with peripartum 
tuberculosis is due to restitution of the patients' immune response 
after delivery. During pregnancy, there is experimental evidence of 
progressive suppression of lymphocytic reactivity towards the 
purified protein derivative of tuberculin, indicating 
pregnancy-associated depression of cell-mediated immunity [4]. 
Recently, it was shown that placental products such as 
progesterone, prostaglandin E2, interleukin-4, and interleukin-10 
can impair the T-helper immune response, and polarization to 
T-helper suppression was also evidenced in peripheral lymphocytes 
in the maternal circulation [15]. As a result of the immune 
suppression, tuberculosis occurring in pregnant women is less 
symptomatic than that in nonpregnant women [16]. After delivery, 
the lymphocytic proliferative response rapidly returns to normal as 
early as 24 h, and complete recovery occurs at 4 weeks postpartum 
[4]. Reversal of T-helper suppression may precipitate either the 
symptomatic onset of peripartum tuberculosis that may have been 
present latently or the worsening of symptoms of tuberculosis during 
pregnancy. Thus, peripartum tuberculosis is a form of 
immunorestitution disease [17]. 
The immunorestitution phenomenon of tuberculosis has been 
reported previously in HIV-positive patients [2], in whom the clinical 
worsening of pre-existing tuberculosis typically occurred when the 
CD4+ lymphocyte count recovered following initiation of highly 
active antiretroviral therapy. Immunorestitution is more likely to 
occur in HIV-positive patients who experience substantial increases 
in CD4+ lymphocyte counts [2]. Recently, we have also reported this 
phenomenon in HIV-negative patients, in whom a surge in 
lymphocyte counts was observed during paradoxical response [3]. 
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In case 2 of the present study, the acute clinical deterioration 
immediately after delivery was associated with a rise in lymphocyte 
counts. Further studies are warranted to elucidate the clinical 
spectrum of immunorestitution disease in non-HIV-infected patients 
with tuberculosis and the association between peripartum 
tuberculosis and a surge in lymphocyte counts. 
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